Drugs
FDA Drug Safety Newsletter Index
| Newsletter Index, Volume 2, 2009 |
| A | B | C | D | E | F | G | H | I | J | K | L | M |
| N | O | P | Q | R | S | T | U | V | W | X | Y | Z |
An index to brand-name drugs, generic drugs and health issues discussed in Drug Safety Newsletter articles. A list of drug safety alerts and communications can be found on the Index to Drug-Specific Information.
Newsletter Index, Volume 1, 2007-2008
Page numbers refer to the print version (PDF).
A
Abacavir, 5-6
Acute Renal Failure, 13-15
ADHD, 7-9
Ageusia, 26-27
AndroGel, 21-23
Anosmia, 26-27
Arginine, 16-18
Atomoxetine, 7-9
B
Bupropion, 1-4
C
Calcium, 24-25
Cardiopulmonary Arrest, 24-25
Ceftriaxone, 24-25
Chantix, 1-4
D
- Drug-Drug Interaction, 24-25
E
- Epzicom, 5-6
H
Hepatotoxicity, 7-9
- HLA-B*570, 5-6
L
Leg Cramps, 11-13
Loss of Sense of Smell, 26-27
Loss of Sense of Taste, 26-27
M
Medication Errors, 16-18
N
Neonates, 24-25
Nicotine, 1-4
Off-label Use, 11-13
P
Pediatrics, 1-4
Q
Qualaquin, 11-13
Quinine Sulfate, 11-13
R
Reclast, 13-15
Renal Impairment, 13-15
R-Gene 10, 16-18
S
Skin Patch Testing, 5-6
- Strattera, 7-9
- Suicide, 1-4
T
Testim, 21-23
Topical Testosterone Gel, 21-23
Topical Transfer, 21-23
Trizivir, 5-6
V
Varenicline, 1-4
Z
Ziagen, 5-6
Zicam, 26-27
Zinc-Containing Intranasal Cold Remedies, 26-27
Zolendronic Acid, 13-15
